bims-ensmum Biomed News
on Exercise and nutrition in skeletal muscle metabolism
Issue of 2026–11–15
six papers selected by
Rachel M. Handy, University of Guelph and Universiteit Mastricht



  1. J Physiol. 2026 Nov 11.
      Exogenous glucose oxidation (CHOexo) is suppressed during endurance exercise performed in hot conditions, although the underlying mechanisms and effects of heat acclimation are unknown. The present study investigated whether heat acclimation alleviates the heat-induced suppression of CHOexo and the underlying physiological mechanisms. Seventeen endurance-trained adults (10 males and seven females) completed 90 min cycling trials at 45% Wmax with glucose ingestion (90 g·h-1) under temperate [20°C; 20% relative humidity (RH); COOL] and hot (40°C; 20% RH; HOT) conditions, and again in the heat (40°C; 20% RH; POST) following a heat acclimation protocol (9 days of isothermic exercise-heat acclimation across a 10 day period). Dual stable isotope tracers ([U13C6] glucose ingestion, [6,6-2H2]glucose-infusion), indirect calorimetry and muscle biopsies were used to assess CHOexo, glucose kinetics and muscle glycogen utilisation during exercise. CHOexo (mean [95% confidence limits]) was reduced by ∼27% in HOT compared to COOL (0.37 [0.31, 0.43] g·min-1 vs. 0.51 [0.45, 0.57] g·min-1; P < 0.001) and, despite clear thermoregulatory adaptation following heat acclimation, remained suppressed in POST (0.38 [0.31, 0.44] g·min-1; P < 0.01 vs. COOL). Rates of plasma glucose appearance, disappearance and exogenous glucose appearance were unaffected by environmental condition or heat acclimation. Glucose metabolic clearance rates and plasma glucose oxidation were reduced in HOT and POST compared to COOL (P < 0.05). A decreased capacity for plasma glucose disposal and utilisation rather than limitations in splanchnic glucose appearance underpin the reduced exogenous glucose oxidation observed during exercise in the heat, and this is not alleviated by heat acclimation. KEY POINTS: Exogenous glucose oxidation is suppressed during endurance-exercise performed in hot conditions, although the underlying mechanisms and effects of heat acclimation are unknown. A decreased capacity for plasma glucose disposal and utilisation rather than limitations in splanchnic glucose appearance appear to underpin the reduced exogenous glucose oxidation observed during exercise in the heat. Heat acclimation does not alleviate the reduction in exogenous glucose oxidation that occurs when exercising in hot conditions.
    Keywords:  carbohydrate; exercise; heat stress; metabolism
    DOI:  https://doi.org/10.1113/JP289304
  2. Aging Cell. 2026 Nov;pii: e70843. [Epub ahead of print]25(11):
      The ability to recover skeletal muscle after periods of disuse declines with age leading to persistent deficits in strength and function that extend beyond muscle mass loss. Here, we investigated whether age-related alterations in lipid remodeling contribute to impairment in skeletal muscle recovery following disuse. Lipidomic and oxylipin profiling revealed that aged mouse muscle is characterized by sustained phosphatidylcholine and omega-6-dependent COX-prostaglandin signaling during early recovery from disuse atrophy. This persistent lipid mediator response was associated with increased senescence burden, fibrosis, and impaired functional recovery. Pharmacological suppression of COX signaling during reloading in aged mice reduced senescence markers, limited fibrosis, and improved muscle function independent of improved muscle size. Mechanistically, senescent induced macrophages produced COX-2-dependent PGE2 and impaired myotube size and fusion through paracrine signaling. Activation of EP2 signaling was sufficient to induce a senescent macrophage phenotype. Importantly, a similar age-associated dysregulation of oxylipin content was observed in older adults after limb immobilization, supporting the translational relevance of these findings. Together, our results identify sustained COX-prostaglandin signaling as a key feature of impaired skeletal muscle recovery with aging and suggest that targeted modulation of this pathway may improve muscle recovery in older individuals. Trial Registration: ClinicalTrials.gov identifier: NCT04416191.
    Keywords:  aging; cellular senescence; cyclooxygenase; disuse atrophy; skeletal muscle; skeletal muscle recovery
    DOI:  https://doi.org/10.1111/acel.70843
  3. J Cachexia Sarcopenia Muscle. 2026 Dec;pii: e70426. [Epub ahead of print]17(6):
       BACKGROUND: Measuring in vivo protein synthesis is important for testing how interventions, disease and ageing remodel the proteome. A limitation of approaches using short-term infusions of labelled amino acids was that long-term changes had to be extrapolated from short-term measurements. Deuterium oxide (D2O) is now widely used because it can measure protein synthesis over periods of days to weeks. We previously showed that the duration of labelling impacts measured protein synthesis, but many still employ repeated tissue sampling during D2O provision. We hypothesized that the timing of tissue sampling alters which proteins contribute to the overall protein fractional synthesis rate (FSR), thereby invalidating comparisons between serial samples collected during continuous labelling.
    METHODS: To test this hypothesis, we used a five-timepoint (0d, 4d, 15d, 30d and 45d) D2O labelling time course followed by liquid chromatography-tandem mass spectrometry proteomics to calculate individual protein synthesis rates and plateau values in mouse gastrocnemius muscle. Individual proteins were stratified into slow and fast groups, such that each group was responsible for the slowest or fastest 20% of total synthesis over the first 4 days of labelling, respectively.
    RESULTS: In a 4-day period representing a baseline period, the synthesis rate of summed proteins was 2.09%/day. When the period was extended to 15, 30 or 45 days, the synthesis rates of summed proteins declined to 1.64%, 1.31% and 1.10%/day, respectively. The contribution of slow and fast proteins to these rates changed as a function of time. The fast and slow proteins accounted for 4.3% and 34.0% of measured proteome abundance, respectively. From Day 0 to Day 4, fast and slow proteins contributed 19.8% and 20.2% of the calculated FSR, respectively. By Day 45, these contributions shifted to 6.5% and 28.8%. Further, we demonstrated that the assumption that the fraction new of proteins linearly increases to 100% new is not true for the majority of proteins. Instead, most proteins plateaued at some point less than 100%, which stops their individual contribution to a summed protein synthesis rate.
    CONCLUSIONS: In continuous long-term labelling studies, biopsy timing changes the measured bulk FSR because the relative contributions of individual proteins to that measurement over time. Fast proteins that plateau early decrease their contribution as labelling time increases. These findings indicate that studies with different labelling periods, or multiple biopsies over time during continuous labelling of days to weeks cannot be compared to biopsies taken at other times in the labelling period.
    Keywords:  biopsy; deuterium oxide; proteomics; skeletal muscle; stable isotopes
    DOI:  https://doi.org/10.1002/jcsm.70426
  4. Med Sci Sports Exerc. 2026 Nov 11.
       PURPOSE: Resistance and endurance exercise produce distinct adaptations, but molecular responses that distinguish these exercise modalities across studies and molecular layers remain incompletely defined. We sought to identify reproducible resistance- and endurance-associated molecular responses across human skeletal muscle and plasma omics datasets.
    METHODS: We integrated publicly available human exercise omics datasets. Random-effects meta-analyses included 15,312 genes from three skeletal muscle RNA-seq datasets and 4,641 proteins from two skeletal muscle proteomic datasets. Early skeletal muscle phosphoproteomic responses were compared across two independent studies using 2,430 matched phosphosites. At 24 hours, skeletal muscle phosphoproteomics and targeted and untargeted metabolomics in skeletal muscle and plasma were analyzed separately; plasma proteomics was not analyzed. Effects were standardized as resistance exercise minus endurance exercise, with significance defined within each molecular layer at FDR<0.05.
    RESULTS: RNA-seq identified 269 genes, including 71 resistance-associated and 198 endurance-associated genes. Global proteomics identified 10 proteins (nine resistance-associated; one endurance-associated). Early phosphoproteomic effects correlated across studies (r=0.589, P=4.1x10-227); 210 of 238 significant phosphosites were directionally concordant, and 51 met replication criteria. At 24 hours, targeted plasma metabolomics identified 14 endurance-associated features, while untargeted plasma metabolomics identified 18 features, including nine resistance-associated and nine endurance-associated features. Resistance-associated responses involved contractile, myofibrillar, cytoskeletal, extracellular matrix, protein quality-control, stress-response, and phosphorylation-related processes. Endurance-associated responses involved mitochondrial oxidative metabolism, respiratory-chain biology, fatty acid oxidation, substrate utilization, amino acid metabolism, and mitochondrial proteostasis.
    CONCLUSIONS: Human molecular responses to resistance and endurance exercise are molecular-layer specific. Endurance-associated responses were more consistently represented in transcriptomic and metabolic layers, whereas resistance-associated responses were more prominent in protein abundance and phosphorylation. These findings provide a quantitative basis for selecting molecular measurements and sampling strategies in future human resistance and endurance exercise studies.
    Keywords:  ENDURANCE EXERCISE; MULTIOMICS; RANDOM-EFFECTS META-ANALYSIS; RESISTANCE EXERCISE; SKELETAL MUSCLE
    DOI:  https://doi.org/10.1249/MSS.0000000000004211
  5. Nat Med. 2026 Nov 09.
      Incretin mimetics as obesity therapy induce substantial weight and fat loss but also decrease lean soft tissue mass, possibly impairing skeletal muscle function. Here, in this two-arm randomized controlled trial of adding resistance exercise (REx) to tirzepatide (T), 120 adults with overweight or obesity were treated with tirzepatide and randomized to thrice-weekly resistance exercise training or usual activities for 40 weeks. Tirzepatide was safe, and most participants tolerated up-titration to 15 mg weekly. Adherence to resistance exercise was 91%. Weight loss achieved was similar (T = -22.61 kg, T+REx = -22.28 kg, P = 0.694). For primary outcomes, loss of total fat mass was similar (T = -17.19 kg, T+REx = -17.98 kg, P = 0.700; between-group difference = -0.77 kg, 95% confidence interval (CI): -2.14 kg to 0.60 kg), but resistance exercise reduced loss of total lean soft tissue mass (T = -4.67 kg, T+REx = -3.57 kg, P < 0.001; between-group difference = 1.09 kg, 95% CI: 0.43-1.75 kg). For related endpoints, resistance exercise reduced loss of appendicular lean soft tissue mass (T = -3.55 kg, T+REx = -2.92 kg, P < 0.001). Upper and lower body muscle strength decreased with tirzepatide (bench press -4.09 kg, lat pulldown -4.42 kg, knee extension -4.42 kg) but increased with T+REx (+4.68 kg, +8.58 kg, +5.88 kg, respectively, all P < 0.001 versus tirzepatide). In conclusion, resistance exercise training attenuated loss of total lean soft tissue mass, representing an effective adjunct to tirzepatide anti-obesity therapy. Australian New Zealand Clinical Trials Registry identifier: ACTRN12623001236684 .
    DOI:  https://doi.org/10.1038/s41591-026-04752-5
  6. Biology (Basel). 2026 Nov 08. pii: 2039. [Epub ahead of print]15(21):
      Remodeling of adipose tissue macrophages (ATMs) during obesity is closely linked to insulin resistance. In addition to soluble mediators, extracellular vesicles (EVs) released by ATMs and their microRNA (miRNA) cargo have been implicated in metabolic communication between adipose tissue and skeletal muscle. Previous studies have shown that EV cargo profiles and metabolic effects can vary across ATM states, adipose depots, and macrophage populations, with some EVs promoting insulin resistance and others improving insulin sensitivity. Among the mechanisms relevant to skeletal muscle, the miR-29a-PPARδ relationship has relatively direct experimental support from ATM-EV studies. The miR-210-3p-GLUT4 relationship is supported by changes in ATM-EV cargo, findings from myocytes and other recipient-cell models, and experiments involving exogenously administered macrophage EVs. However, this relationship has not been fully validated within a single ATM-EV-skeletal muscle experimental system. Studies involving miR-690 also suggest that EVs from certain macrophage populations can improve insulin sensitivity, although the molecular annotation of miR-690, its reported direct targeting mechanism, and the applicability of these findings to humans remain under debate. Overall, these findings implicate ATM-derived EVs in metabolic regulation, while their physiological effects on skeletal muscle in humans remain uncertain.
    Keywords:  adipose tissue macrophages; extracellular vesicles; insulin sensitivity; microRNA; obesity; skeletal muscle
    DOI:  https://doi.org/10.3390/biology15212039